
Bioregulators
Thymalin
Thymalin is not a single defined peptide. It is a polypeptide complex extracted from calf thymus, with components up to about 10 kDa; the dipeptides Lys-Glu and Glu-Trp are described as active constituents.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 20 mg, lot THYM20-0318: 99.80% purity (RP-HPLC), 18.79 mg measured, identity confirmed by mass spec. Issued 2026-04-03 by Bioviridian Inc.. Verify certificate COA3390
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- T-lymphocyte differentiation
- Immune function during infection
- COVID-19 add-on treatment studies
- Inflammatory cytokine production
How it is thought to work
Its developers state that the molecular mechanism requires further study. In culture, thymalin lowered the stem-cell markers CD44 and CD117 and raised CD28 on human hematopoietic stem cells, read as a shift toward mature T lymphocytes. In human blood mononuclear cells it lowered IL-1beta, IL-6 and TNF-alpha production after lipopolysaccharide exposure.
Where the research stands
Registered drug in Russia (thymus extract); no FDA approval found. One source states thymalin has been approved for medical use in Russia as an immunomodulator since 1982. The COVID-19 trial opened here was single-center and open-label with 92 patients. No FDA label or ClinicalTrials.gov record was found; this describes the registered Russian product, not research-grade material.
Sources
- Khavinson VK, et al. (2020). Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bulletin of Experimental Biology and Medicine.
- Khavinson VK, et al. (2021). Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19. Stem Cell Reviews and Reports.
- Linkova N, et al. (2023). The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. International Journal of Molecular Sciences.
- Avolio F, et al. (2022). Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International Journal of Molecular Sciences.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
